India supplying vaccine doses to several nations: MEA

As we announced on Tuesday, our grant assistance of vaccines to the neighbouring countries commenced Wednesday.

Published: 23rd January 2021 09:47 AM  |   Last Updated: 23rd January 2021 09:47 AM   |  A+A-

Indian Ambassador to Myanmar Saurabh Kumar (wearing tie) with consignment of Covishield vaccine at Yangon International Airport on Friday| PTI

By Express News Service

NEW DELHI:  The Ministry of External Affairs (MEA) on Friday said it was yet to receive any request for the supply of made-in-India coronavirus vaccines from Pakistan, even as the government has sent consignments of doses under grant assistance to Bhutan, Maldives, Nepal, Bangladesh, Myanmar, Mauritius and Seychelles.

At a media briefing, MEA spokesperson Anurag Srivastava said India is also undertaking commercial supplies of the vaccines to a number of countries, including Saudi Arabia, South Africa, Brazil and Morocco.“I am not aware of any request for the supply of Indian made vaccines to Pakistan on a government-to-government (G2G) basis or commercial basis. As we announced on Tuesday, our grant assistance of vaccines to the neighbouring countries commenced Wednesday.

On the first day, 1.5 lakh doses of vaccines were supplied to Bhutan and 1 lakh doses to the Maldives as grant assistance. On Thursday, supplies of 10 lakh doses to Nepal and 20 lakh doses to Bangladesh were undertaken. Consignments of 15 lakh doses for Myanmar, 1 lakh doses to Mauritius and 50,000 doses to Seychelles are being airlifted,” he said. 

He said vaccine supply as grant assistance to Sri Lanka and Afghanistan will be undertaken after receiving confirmation of regulatory clearances from these two countries.  “Contractual supplies are also being undertaken to Saudi Arabia, South Africa, Brazil, Morocco, Bangladesh and Myanmar,” he said.On being asked about quantities and types of vaccines, the MEA spokesperson said India-made vaccines supplies are underway both as gifts as well as on commercial basis. “The supplies abroad on G2G, G2B and B2B basis would be based on availability and regulatory approvals in the countries concerned,” he said.


Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.